Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 34 for “"Sandhoff"”.

  1. Investigating Sandhoff Disease in Saskatchewan

    Sandhoff disease is an autosomal recessive lysosomal storage disease caused by mutations in the HEXB gene detrimentally affecting the enzyme β-hexosaminidase. A high incidence of Sandhoff disease has been reported in northern Saskatchewan. The variant of the disease present in the province causes …

    regina Repository record for Investigating Sandhoff Disease in Saskatchewan (opens in a new tab) Download PDF for Investigating Sandhoff Disease in Saskatchewan (opens in a new tab)

  2. TUMOR NECROSIS FACTOR ALPHA (TNFα) in SANDHOFF DISEASE PATHOLOGY

    <p><strong>Abstract</strong></p> <p>Sandhoff disease (SD) is a monogenic lysosomal storage disorder caused by a lack of a functional β-subunit of the beta-hexosaminidase A and B enzymes. The clinical phenotype of <em>Hexb</em><sup>-/-</sup>mouse model recapitulates the symptoms and signs of …

    mcmaster Repository record for TUMOR NECROSIS FACTOR ALPHA (TNFα) in SANDHOFF DISEASE PATHOLOGY (opens in a new tab)

  3. Partial Molecular and Biochemical Characterization of a Sandhoff Mouse Model

    Sandhoff Disease (SD) is a rare genetic disorder which results in progressive neurodegeneration. SD is caused by a build-up of GM2 Gangliosides, a lipid which is stored in the lysosome of neurons. It can occur in infantile, juvenile and adult forms; in the severe, infantile form, death occurs by …

    queens Repository record for Partial Molecular and Biochemical Characterization of a Sandhoff Mouse Model (opens in a new tab)

  4. Autophagy dysfunctions and lysosomal permeabilization in Tay-Sachs and Sandhoff diseases

    … 2016), (Munson & Ganley, 2015). Tay-Sachs and Sandhoff are two rare inherit LSDs which affect the nervous system and are characterized by early neuronal cell death and progressive neurodegeneration. They are caused by a mutation in a gene which encodes for the α (Tay-Sachs) and β (Sandhoff) …

    sevilla Repository record for Autophagy dysfunctions and lysosomal permeabilization in Tay-Sachs and Sandhoff diseases (opens in a new tab)

  5. THE ENDOPLASMIC RETICULUM STRESS RESPONSE IN THE PROGRESSION OF SANDHOFF DISEASE

    Sandhoff disease (SD), a fatal lysosomal storage disease, results from a deficiency of the β-subunit of the β-hexosaminidase A and B enzymes. This deficiency leads to severe accumulation of GM2 gangliosides in lysosomes within the central nervous system (CNS) resulting in mass neuronal apoptosis. …

    mcmaster Repository record for THE ENDOPLASMIC RETICULUM STRESS RESPONSE IN THE PROGRESSION OF SANDHOFF DISEASE (opens in a new tab)

  6. Enhancement of a novel gene therapy approach for Sandhoff disease through complimentary drug therapy

    … disease, or a mutation to the HEXB gene, causing Sandhoff disease. The HEXA and HEXB genes are required to produce the α and β subunits of the Hex A enzyme respectively. Using a Sandhoff disease (SD) mouse model (Hexb-/-) we tested the potential of a low dose of systemically delivered single …

    queens Repository record for Enhancement of a novel gene therapy approach for Sandhoff disease through complimentary drug therapy (opens in a new tab)

  7. Lysosomal storage and pathologenesis in a novel in vitro cellular model of Sandhoff disease

    <p>Sandhoff disease is a devastating autosomal recessive GM2 gangliosidosis in which a deficiency of β-hexosaminidase results in lysosomal storage of the enzyme's substrates, including GM2 and GA2 glycolipid as well as glycoprotein-derived oligosaccharides (OS). The effect of individual storage …

    oxford Restricted access

  8. Assessing the potential of rAAV9 systemic gene therapy for GM2 gangliosidoses using a Sandhoff mouse model

    … damage and death in the early years of life. Sandhoff mice deficient in both major hexosaminidase isozymes, Hex A and Hex B, mimic the disease severity in the human condition including the motor deterioration, histopathological findings, and premature death. To investigate the utility of …

    manitoba Repository record for Assessing the potential of rAAV9 systemic gene therapy for GM2 gangliosidoses using a Sandhoff mouse model (opens in a new tab)

  9. MECHANISMS OF NEURODEGENERATION IN A MOUSE MODEL OF SANDHOFF DISEASE: ROLES OF INFLAMMATION, EXCITOTOXICITY, AND APOPTOSIS

    … The GM2 Gangliosidoses, Tay-Sachs disease and Sandhoff disease, are pathologically overlapping lysosomal storage disorders, with high prevalence within specific ethnicities. Their effects are neurologically devastating and often fatal at young ages. Current treatments only slow or stall an …

    mcmaster Repository record for MECHANISMS OF NEURODEGENERATION IN A MOUSE MODEL OF SANDHOFF DISEASE: ROLES OF INFLAMMATION, EXCITOTOXICITY, AND APOPTOSIS (opens in a new tab)

  10. Uncovering the Role of Progranulin in Ameliorating Lysosomal Storage Disease

    … modulator, granulin (GRN), and its role in Sandhoff disease. GRN deficiency has been shown to promote neuroinflammation, neuronal death, and leads to a lysosomal storage disorder (LSD) 1-7. Complete loss of GRN causes Batten’s disease (CLN11), which belongs to a class of LSDs1. …

    dominican Repository record for Uncovering the Role of Progranulin in Ameliorating Lysosomal Storage Disease (opens in a new tab)

  11. Metabolism of Glycosphingolipids and targeting GM2 synthesis pathway to develop substrate reduction approach in Tay-Sachs and Sandhoff disorders.

    … available presently. Tay-Sachs (TSD) and Sandhoff disorders (SD) are caused by a disruption of the catabolic pathway of gangliosides in lysosomes, accumulating GM2 and lyso-GM2, which damage cells and tissues. This leads to symptoms that often include neurological deterioration, such as …

    queens Repository record for Metabolism of Glycosphingolipids and targeting GM2 synthesis pathway to develop substrate reduction approach in Tay-Sachs and Sandhoff disorders. (opens in a new tab)

  12. Tay-Sachs Disease: Mechanisms of Neuropathology and Potential Therapeutic Strategies Utilizing Human Lysosomal Sialidase

    … Included in this group are Tay-Sachs and Sandhoff disease. Human cases of Tay-Sachs and Sandhoff disease present with devastating neurological deterioration; however, murine models display drastically divergent phenotypes. Tay-Sachs mice avoid pathology via a sialidase-mediated bypass of …

    mcmaster Repository record for Tay-Sachs Disease: Mechanisms of Neuropathology and Potential Therapeutic Strategies Utilizing Human Lysosomal Sialidase (opens in a new tab)

  13. Intrathecal Delivery of a Human Bicistronic Hexosaminidase Vector to Correct Sandhoff Disease in a Murine Model: A Dose-Response Study

    … disorders including Tay-Sachs disease (TSD), Sandhoff disease (SD), and the AB variant of GM2 gangliosidosis. TSD and SD are characterized by reduced or absent levels of the hydrolase β-hexosaminidase A (Hex A). Normally, the heterodimer Hex A hydrolyzes GM2 ganglioside into GM3, however if …

    queens Repository record for Intrathecal Delivery of a Human Bicistronic Hexosaminidase Vector to Correct Sandhoff Disease in a Murine Model: A Dose-Response Study (opens in a new tab)

  14. Induction of Immune Tolerance to Hexosaminidase M Using Rapamycin and Prednisone in the scAAV9-HEXM Gene Therapy Treatment of Sandhoff Disease

    Sandhoff disease (SD) is a neurodegenerative disorder caused by the toxic accumulation of GM2 gangliosides in the brain. This is due to a deficient enzyme, β-hexosaminidase A (HEXA), involved in the catabolism of GM2 gangliosides. A recently constructed isoenzyme analogous to HEXA, called …

    queens Repository record for Induction of Immune Tolerance to Hexosaminidase M Using Rapamycin and Prednisone in the scAAV9-HEXM Gene Therapy Treatment of Sandhoff Disease (opens in a new tab)

  15. Long Term Correction of GM2 Gangliosidoses in Sandhoff Mice Through Intravenous Neonatal Gene Therapy, Using a Recombinant Adeno-Associated Viral Vector Expressing a New Hexosaminidase Variant

    … an innovative gene therapy treatment method in a Sandhoff (β-subunit deficient) mouse model. The treatment utilized a new engineered variant of Hexosaminidase isoenzyme, HexM, which is formed by the homodimerization of a modified human Hex α-subunit called Hex µ, which contains critical …

    queens Repository record for Long Term Correction of GM2 Gangliosidoses in Sandhoff Mice Through Intravenous Neonatal Gene Therapy, Using a Recombinant Adeno-Associated Viral Vector Expressing a New Hexosaminidase Variant (opens in a new tab)

  16. Preclinical Assessment of the scAAV9-HEXM Gene Therapy Vector via a Novel Combined Delivery Method in the Treatment of Sandhoff Disease in a Murine Model

    Sandhoff disease (SD) is a genetic neurodegenerative disorder caused by an excessive accumulation of GM2 gangliosides in neuronal lysosomes. SD arises from a mutation in the HEXB gene which encodes the β-subunit of the enzyme, β-hexosaminidase A, a heterodimer responsible for the hydrolysis of GM2. …

    queens Repository record for Preclinical Assessment of the scAAV9-HEXM Gene Therapy Vector via a Novel Combined Delivery Method in the Treatment of Sandhoff Disease in a Murine Model (opens in a new tab)

  17. Elucidating the structure and improving the cellular uptake of HexM, a candidate for enzyme replacement therapy of GM2 gangliosidosis

    Tay-Sachs disease and Sandhoff disease are genetic disorders resulting from mutations in genes HEXA or HEXB, which code for the α- and β-subunits of the heterodimer β-hexosaminidase A (HexA), respectively. HexA is a lysosomal glycosidase responsible for degrading GM2 ganglioside (GM2), a glycolipid …

    manitoba Repository record for Elucidating the structure and improving the cellular uptake of HexM, a candidate for enzyme replacement therapy of GM2 gangliosidosis (opens in a new tab)

  18. Preclinical Assessment of Intravenous Gene Therapy for GM2 Gangliosidosis

    … of these genes lead to Tay Sachs Disease and Sandhoff Disease, respectively, through the disruption of the HexA enzyme. These debilitating diseases are fatal by the age of 4 in the infantile version and have no effective treatment available to patients other than palliative care. Herein we …

    queens Repository record for Preclinical Assessment of Intravenous Gene Therapy for GM2 Gangliosidosis (opens in a new tab)

  19. Röntgenstrukturanalyse von Proteinen des humanen Sphingolipid-Stoffwechsels

    … Sphingolipid-Speicherkrankheiten Tay-Sachs- und Sandhoff-Krankheit zeigt. Das dimere Enzym kommt in drei Isoformen, HexA (αβ), HexB (ββ) und HexS (αα), vor, die durch die Kombination zweier nahe verwandter Untereinheiten, α und β, entstehen. In dieser Arbeit wurde die Röntgenkristallstruktur von …

    fu-berlin Repository record for Röntgenstrukturanalyse von Proteinen des humanen Sphingolipid-Stoffwechsels (opens in a new tab)

Page 1 of 2